- Report
- June 2024
- 180 Pages
Global
From €4043EUR$4,500USD£3,523GBP
- Report
- November 2023
- 185 Pages
Global
From €4043EUR$4,500USD£3,523GBP
- Report
- October 2023
- 82 Pages
United States
From €3144EUR$3,500USD£2,740GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1797EUR$2,000USD£1,566GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2695EUR$3,000USD£2,349GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1797EUR$2,000USD£1,566GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1797EUR$2,000USD£1,566GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1797EUR$2,000USD£1,566GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1797EUR$2,000USD£1,566GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1348EUR$1,500USD£1,174GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1123EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1123EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1123EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1123EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1123EUR$1,250USD£979GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more